Drug production

Bayer to invest USD 200 million in production plant in Costa Rica.

Bayer recently announced the expansion of its Latin American operations with the opening of a new production facility at Coyol Industrial Park in Alajuela, Costa Rica. The company will invest USD 200 million in the site which will specialise in the production of contraceptive drugs for women in low- and middle-income countries.

A spokesperson for Bayer in Costa Rica commented, “We have been in Costa Rica for a long time, it is our hub for the Andean Countries, Central America and the Caribbean region. Across this region, we have 12 main offices, 6 warehouses, 6 production plants, 4 research centres and 1 shared services centre. The new production site in Costa Rica complements one we already have in Finland and is focused on hormonal implants and hormonal intrauterine systems to meet the growing global demand for long-acting reversible contraceptives.

“The new production site in Costa Rica complements one we already have in Finland and is focused on hormonal implants and hormonal intrauterine systems.”

Spokesperson, Bayer, Costa Rica

Latin America is a strategic market for Bayer, not only in the field of human medicine but also for its agricultural chemicals division. Bayer employs almost 14,000 people in Latin America, which generated USD 5.9 billion in sales in 2020.

Christian Meyer, head of Bayer Central America, said that the multinational chose Costa Rica due to its business-friendly climate, human talent and sustainability policies which could potentially attract further private investment. Furthermore, the production of the new plant will be mainly destined to health programmes developed and implemented by the United Nations Population Fund and the US Agency for International Development.

A government trade official was delighted with the announcement, “This is a manufacturing plant for a complex combined device with a pharmaceutical component, in this case hormones for long-term contraception. This is the third-largest product in Bayer’s biopharmaceutical division and means that the employees in this plant will need to be highly skilled. The company will work hand-in-hand with the Costa Rican lnvestment Promotion Agency (“CINDE”) and the Ministry of Labor to strengthen and develop the human talent required.”

“The company will work hand-in-hand with CINDE and the Ministry of Labor to strengthen and develop the human talent required.”

Government trade official, Costa Rica

Costa Rica hosts 6 of the world’s top 10 pharmaceutical companies and has long been a strategic destination for these companies in the service sector. Roche has been there for 48 years and has a 300,000 square foot campus with over 1,000 employees. Pfizer also has its regional hub for Central America and the Caribbean in Costa Rica and AstraZeneca has a financial services team there that covers the entire continent.

Costa Rica’s life sciences industry continues to grow!


Important Notice
While the information in this article has been prepared in good faith, no representation, warranty, assurance or undertaking (express or implied) is or will be made, and no responsibility or liability is or will be accepted by Deheza Limited or by its officers, employees or agents in relation to the adequacy, accuracy, completeness or reasonableness of this article, or of any other information (whether written or oral), notice or document supplied or otherwise made available in connection with this article. All and any such responsibility and liability is expressly disclaimed.
This article has been delivered to interested parties for information only. Deheza Limited gives no undertaking to provide the recipient with access to any additional information or to update this article or any additional information, or to correct any inaccuracies in it which may become apparent.

Most recent in Health

Battling the Buzz

Dengue wars in Latin America.

Galloping Ahead

Argentina’s cloning industry breaks new ground.

Revolutionising pharmaceutical services 

Challenges and opportunities in the Americas. 

LatAm’s fight for a healthier tomorrow

The region's efforts to defeat Hepatitis.

Diabetes spikes

A public health crisis is emerging as diabetes runs rampant across Latin America.

Sleep on it

A recent study claims 3 in 4 Argentinians suffer from some form of sleep disturbance.

Health collapse

Chile’s private health insurance companies face bankruptcy at the hands of government legislation.

Cholera outbreak

PAHO delivers over a million cholera vaccine doses to Haiti as outbreak gathers pace.

Birth dearth

Latin America’s fertility rate continues to fall but what does this mean for the region?

Digital remedies

Digital pharmacies growing rapidly after pandemic induced change in consumer behaviour.